Tag: warrant

HOUSTON, June 26, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the "Company" or "Decoy"), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a new...

Cartesian Growth Corporation IV announced today the closing of its initial public offering of 27,500,000 units.

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Acquisition Corp (Nasdaq: FWACU, the “Company”) announced today that it closed its initial public offering (“IPO”) of 8,625,000 units at an offering price of $10.00 per unit, including the 1,125,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option, resulting in aggregate gross proceeds of $86,250,000, before deducting underwriting discounts and estimated offering expenses.

DENVER, June 25, 2026 /CNW/ - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based critical materials company focused on uranium, rare earth...

DENVER, June 25, 2026 /PRNewswire/ - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based critical materials company focused on uranium, rare earth...

VANCOUVER, BC, June 25, 2026 /CNW/ - Soma Gold Corp. (TSXV: SOMA) (WKN: A2P4DU) (OTC: SMAGF) (the "Company" or "Soma") is pleased to announce...

Coolizi launches 2026 Cooling Ace personal evaporative cooler with energy-efficient operation and direct-to-consumer availability.

                                                                Charenton-le-Pont, 25 June 2026

Updated features help consumers manage collection activity, reduce unwanted collector contact, identify potential rights issues, and explore legal support options through independent attorneys.

Updated features help consumers manage collection activity, reduce unwanted collector contact, identify potential rights issues, and explore legal support options through independent attorneys.

DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 32,500,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 833,333 shares of its common stock at an offering price of $5.999 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering to Taysha are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about June 26, 2026, subject to customary closing conditions.

RUTHERFORD, N.J., June 24, 2026 /PRNewswire/ -- Kreyco Inc., a provider of educational services to New York City public schools between 2023 and 2025,...

Cartesian Growth Corporation IV announced today the pricing of its initial public offering of 25,000,000 units, at a price of $10.00 per unit.

FN Media Group Presents Oilprice.com Market CommentaryNEW YORK, June 23, 2026 /CNW/ -- In 2024, China announced export controls on antimony. It's a metal most...